Scholarlink

Background <p>Acute respiratory failure (ARF) is the most common organ failure, affecting up to 30% of all intensive care unit (ICU) admissions. Since vitamin deficiencies are frequent in critically ill patients, and considering that the two primary mechanisms involved in ARF are inflammation and oxidative stress, this study aims to investigate the effects of co-supplementation of vitamins D and C on inflammatory parameters, oxidative stress, and clinical outcomes in critically ill ARF patients.</p> Methods <p>In this double-blind, randomized, placebo-controlled trial, ARF patients admitted to the ICU were randomly assigned to either the intervention group (daily 2000&#xa0;mg of intravenous vitamin C plus 5000 IU of oral vitamin D) or the control group (placebo). The intervention lasted 10 days, and patients were followed for 90 days, assessing inflammation, oxidative stress parameters, and clinical outcomes.</p> Results <p>Thirty-four patients in the intervention group and 33 in the control group completed the trial. At the end of the intervention, High-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and malondialdehyde (MDA) were significantly reduced, while total antioxidant capacity (TAC) increased significantly in the intervention group compared to both the baseline and the control group (<i>p</i> &lt; 0.001). Among the clinical outcomes, only the duration of ICU stay was shorter in the intervention group (0.028). However, 90-day survival (HR 0.55; 95% CI 0.21–1.41; <i>P</i> = 0.22) did not show a significant difference between the two groups.</p> Conclusions <p>Our study concluded that vitamin D and C supplementation may improve inflammation and oxidative status in critically ill ARF patients, reducing ICU stays but not affecting 90-day mortality.</p> Trial registration <p>The study has been registered at <a href="https://irct.behdasht.gov.ir/">https://irct.behdasht.gov.ir/</a>. Number: IRCT20090822002365N29.Registered on 2023-08-05 and it was ethically approved by the Committee of Iran University of Medical Sciences (registration IR.IUMS.REC.1402.210).</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical randomized trial of vitamin D and C supplementation in critically ill patients with respiratory failure

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月29日

查看全文
  • Aynaz velayati,
  • Mohammadreza vafa,
  • Mahdi Yadollahzadeh,
  • Zahra Vahdat Shariat panahi,
  • parvin sarbakhsh,
  • Hamidreza salemi

摘要

Background

Acute respiratory failure (ARF) is the most common organ failure, affecting up to 30% of all intensive care unit (ICU) admissions. Since vitamin deficiencies are frequent in critically ill patients, and considering that the two primary mechanisms involved in ARF are inflammation and oxidative stress, this study aims to investigate the effects of co-supplementation of vitamins D and C on inflammatory parameters, oxidative stress, and clinical outcomes in critically ill ARF patients.

Methods

In this double-blind, randomized, placebo-controlled trial, ARF patients admitted to the ICU were randomly assigned to either the intervention group (daily 2000 mg of intravenous vitamin C plus 5000 IU of oral vitamin D) or the control group (placebo). The intervention lasted 10 days, and patients were followed for 90 days, assessing inflammation, oxidative stress parameters, and clinical outcomes.

Results

Thirty-four patients in the intervention group and 33 in the control group completed the trial. At the end of the intervention, High-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and malondialdehyde (MDA) were significantly reduced, while total antioxidant capacity (TAC) increased significantly in the intervention group compared to both the baseline and the control group (p < 0.001). Among the clinical outcomes, only the duration of ICU stay was shorter in the intervention group (0.028). However, 90-day survival (HR 0.55; 95% CI 0.21–1.41; P = 0.22) did not show a significant difference between the two groups.

Conclusions

Our study concluded that vitamin D and C supplementation may improve inflammation and oxidative status in critically ill ARF patients, reducing ICU stays but not affecting 90-day mortality.

Trial registration

The study has been registered at https://irct.behdasht.gov.ir/. Number: IRCT20090822002365N29.Registered on 2023-08-05 and it was ethically approved by the Committee of Iran University of Medical Sciences (registration IR.IUMS.REC.1402.210).